Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
0 hedge funds and large institutions have $0 invested in Petros Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 14 closing their positions.
0.15% less ownership
Funds ownership: 0.15% → 0% (-0.15%)
100% less funds holding
Funds holding: 14 → 0 (-14)
100% less capital invested
Capital invested by funds: $77.6K → $0 (-$77.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$38.9K |
| 2 |
HF
HRT Financial
New York
|
-$9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.22K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.47K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| – | -$38.9K | -22,544 | Closed |
|
|
HF
2
HRT Financial
New York
| – | -$9K | -5,501 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$8.22K | -4,763 | Closed |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| – | -$7.47K | -4,327 | Closed |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| – | -$6.28K | -3,636 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$4.24K | -2,454 | Closed |
|
7
Vanguard Group
Malvern,
Pennsylvania
| – | -$2.19K | -1,272 | Closed |
|
8
BlackRock
New York
| – | -$1.11K | -645 | Closed |
|
9
Morgan Stanley
New York
| – | -$48 | -28 | Closed |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| – | -$22 | -13 | Closed |
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$14 | -8 | Closed |
|
12
Osaic Holdings
Scottsdale,
Arizona
| – | -$14 | -8 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$5 | -3 | Closed |
|
14
Group One Trading
Chicago,
Illinois
| – | -$5 | -3 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$1 | – | – |
|
PTPI Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q2 2025, worth a combined $0 — down 100% from $77.6K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of PTPI and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $38.9K sold.
- 0 institutional investors held Petros Pharmaceuticals (PTPI) as of Q2 2025, down from 14 in Q1 2025.
- Funds reported $0 of Petros Pharmaceuticals stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Petros Pharmaceuticals positions in Q2 2025 and 14 closed out, a net change of -14 holders.
- The largest Petros Pharmaceuticals seller in Q2 2025 was Jane Street, an estimated $38.9K sold.
Based on aggregated 13F filings for Q2 2025.